VIH.BK(VIH.BK)
VIH.BK
No analyst ratings available
No analyst price targets available for VIH.BK
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.97B | $3.17B | $3.44B |
| Low | $2.97B | $3.17B | $3.44B |
| High | $2.97B | $3.17B | $3.44B |
| EBITDA Avg | $766M | $818M | $887M |
| Low | $766M | $818M | $887M |
| High | $766M | $818M | $887M |
| EBIT Avg | $607M | $647M | $702M |
| Low | $607M | $647M | $702M |
| High | $607M | $647M | $702M |
| Net Income Avg | $341M | $389M | $359M |
| Low | $341M | $389M | $359M |
| High | $341M | $389M | $359M |
| EPS Avg | $0.56 | $0.64 | $0.59 |
| Low | $0.56 | $0.64 | $0.59 |
| High | $0.56 | $0.64 | $0.59 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |